With effect from Nov 9, prices of 137 anti-cancer drugs like to drop
NEW DELHI: Trade margins of 137 medicines, including several patented drugs such as pembrolizumab, ribociclib and abemaciclib, have been capped at 30% over the cost at the first point of sale, either the stockist or the hospital, when it is…
Read More...
Read More...